Physiological changes in neurodegeneration — mechanistic insights and clinical utility | Nature Reviews Neurology
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association | Stroke
SQSTM1/p62: A Potential Target for Neurodegenerative Disease | ACS Chemical Neuroscience
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. - Abstract - Europe PMC
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease - Hansson - 2022 - Alzheimer's & Dementia - Wiley Online Library
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation | Alzheimer's Research & Therapy | Full Text
Frontiers | Re-thinking the Etiological Framework of Neurodegeneration
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. - Abstract - Europe PMC
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
Empowering Physicians to Advance the Future of Alzheimer's Disease - EMJ
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? | Insights into Imaging | Full Text
Biomarkers for neurodegenerative diseases | Nature Medicine
Recent Research into Neurodegenerative Diseases
The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review | Journal of Nuclear Medicine
Biomarkers for neurodegenerative diseases | Nature Medicine
Full article: The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Biomarkers for neurodegenerative diseases | Nature Medicine
The biomarker-based diagnosis of Alzheimer's disease. 2—lessons from oncology - ScienceDirect
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021 | SpringerLink
Recognizing Subtle Signs of Early Stage Neurodegeneration - Holistic Primary Care
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Neuroimmune Connections in Aging and Neurodegenerative Diseases: Trends in Immunology
Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
Preclinical markers of neurodegenerative diseases | Download Table
Cerebrospinal fluid biomarkers to monitor treatment effects in Alzheimer's disease and related conditions